Hemant Surgical Industries Ltd
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
- Market Cap ₹ 102 Cr.
- Current Price ₹ 98.0
- High / Low ₹ 225 / 88.2
- Stock P/E 12.6
- Book Value ₹ 60.3
- Dividend Yield 0.00 %
- ROCE 16.4 %
- ROE 13.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 74.7% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Earnings include an other income of Rs.5.11 Cr.
- Working capital days have increased from 58.9 days to 86.6 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 51 | 56 | 56 | 60 | 101 | 109 | 106 | 107 | |
| 48 | 53 | 53 | 57 | 95 | 98 | 95 | 97 | |
| Operating Profit | 2 | 3 | 3 | 3 | 6 | 11 | 10 | 9 |
| OPM % | 5% | 5% | 5% | 5% | 6% | 10% | 10% | 9% |
| 0 | 0 | 0 | 1 | 2 | 2 | 4 | 5 | |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 |
| Depreciation | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | 1 | 1 | 6 | 10 | 13 | 11 |
| Tax % | 10% | 8% | 41% | 9% | 25% | 24% | 23% | 23% |
| 1 | 1 | 0 | 1 | 5 | 8 | 10 | 8 | |
| EPS in Rs | 50.76 | 61.02 | 27.00 | 73.43 | 248.92 | 9.95 | 9.39 | 7.79 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 2% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 75% |
| 3 Years: | 21% |
| TTM: | -17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 22% |
| Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 8 | 10 | 10 |
| Reserves | 5 | 6 | 5 | 8 | 11 | 16 | 44 | 53 |
| 9 | 11 | 14 | 14 | 10 | 7 | 7 | 31 | |
| 12 | 14 | 23 | 15 | 32 | 34 | 35 | 54 | |
| Total Liabilities | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 148 |
| 7 | 8 | 10 | 11 | 12 | 13 | 18 | 40 | |
| CWIP | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 12 |
| Investments | -0 | -0 | 1 | 0 | 1 | 0 | 5 | 1 |
| 21 | 25 | 33 | 29 | 42 | 51 | 74 | 94 | |
| Total Assets | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 148 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| -0 | -0 | 2 | -4 | 12 | 6 | -8 | 9 | |
| -0 | -0 | -2 | -2 | -0 | -3 | -9 | -30 | |
| -0 | -0 | 2 | 5 | -8 | -1 | 21 | 18 | |
| Net Cash Flow | -0 | -0 | 2 | -2 | 4 | 3 | 5 | -4 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 35 | 36 | 35 | 26 | 56 | 58 | 75 | 70 |
| Inventory Days | 64 | 73 | 125 | 113 | 57 | 67 | 99 | 205 |
| Days Payable | 102 | 97 | 143 | 89 | 92 | 110 | 116 | 188 |
| Cash Conversion Cycle | -3 | 12 | 17 | 51 | 21 | 15 | 58 | 87 |
| Working Capital Days | 12 | 23 | 14 | 66 | 2 | 16 | 74 | 87 |
| ROCE % | 15% | 12% | 14% | 32% | 45% | 30% | 16% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Company exempt from Annual Secretarial Compliance Report as listed on BSE SME segment.
-
Statement Of Deviation & Variation
28 May - No deviation in utilization of Rs. 24.84 Cr IPO funds as of March 31, 2025.
- Audited Results For Half And Financial Year Ended March 31, 2025 28 May
-
Board Meeting Outcome for Held On Wednesday, May 28, 2025
28 May - Audited FY25 results approved; fire caused Rs 116.53L asset loss, Rs 387.87L inventory loss partially insured.
-
Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For Half And Financial Year Ended On March 31, 2025.
16 May - Board meeting on May 28 to approve audited results for half and full year ending March 31, 2025.
Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions